213
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Exploring the drug resistance mechanism of active site, non-active site mutations and their cooperative effects in CRF01_AE HIV-1 protease: molecular dynamics simulations and free energy calculations

, &
Pages 2608-2626 | Received 21 Feb 2018, Accepted 10 Jun 2018, Published online: 10 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pretisha Flora Cutinho, Ravi C. Shankar, Avinash Anand, Jaydeep Roy, Chetan H. Mehta, Usha Y. Nayak & Manikanta Murahari. (2020) Hit identification and drug repositioning of potential non-nucleoside reverse transcriptase inhibitors by structure-based approach using computational tools (part II). Journal of Biomolecular Structure and Dynamics 38:13, pages 3772-3789.
Read now

Articles from other publishers (2)

Mouna Baassi, Mohamed Moussaoui, Hatim Soufi, Sanchaita Rajkhowa, Ashwani Sharma, Subrata Sinha & Said Belaaouad. (2023) Towards designing of a potential new HIV-1 protease inhibitor using QSAR study in combination with Molecular docking and Molecular dynamics simulations. PLOS ONE 18:4, pages e0284539.
Crossref
Yanming Chen, Yafeng Tian, Ya Gao, Fengshou Wu, Xiaogang Luo, Xiulian Ju & Genyan Liu. (2020) In silico Design of Novel HIV-1 NNRTIs Based on Combined Modeling Studies of Dihydrofuro[3,4-d]pyrimidines. Frontiers in Chemistry 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.